Christopher R. Cline

Insider Reports History

Location
San Diego, CA
Signature
/s/ Elizabeth E. Reed, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher R. Cline:

Company Role Class Num Shares Value Price $ Report Date Ownership
Travere Therapeutics, Inc. CHIEF FINANCIAL OFFICER Common Stock 112,971 $3,628,628 $32.12 03 Feb 2026 Direct
Travere Therapeutics, Inc. CHIEF FINANCIAL OFFICER Employee stock option (right to buy) 75,000 31 Jan 2026 Direct
Travere Therapeutics, Inc. CHIEF FINANCIAL OFFICER Performance-based restricted stock units 4,920 02 May 2025 Direct

Insider Reports Filed by Christopher R. Cline

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TVTX Travere Therapeutics, Inc. 04 Feb 2026 2 -$56,168 4 CHIEF FINANCIAL OFFICER 05 Feb 2026, 16:05
TVTX Travere Therapeutics, Inc. 31 Jan 2026 3 -$232,613 4 CHIEF FINANCIAL OFFICER 03 Feb 2026, 21:30
TVTX Travere Therapeutics, Inc. 01 Dec 2025 3 -$375,602 4 CHIEF FINANCIAL OFFICER 03 Dec 2025, 16:30
TVTX Travere Therapeutics, Inc. 03 Sep 2025 2 -$10,608 4 CHIEF FINANCIAL OFFICER 05 Sep 2025, 16:05
TVTX Travere Therapeutics, Inc. 27 Aug 2025 1 -$8,136 4 CHIEF FINANCIAL OFFICER 28 Aug 2025, 16:05
TVTX Travere Therapeutics, Inc. 02 May 2025 3 -$37,553 4 CHIEF FINANCIAL OFFICER 05 May 2025, 21:54
TVTX Travere Therapeutics, Inc. 11 Apr 2025 1 -$631 4 CHIEF FINANCIAL OFFICER 14 Apr 2025, 18:23
TVTX Travere Therapeutics, Inc. 31 Jan 2025 3 -$104,463 4 CHIEF FINANCIAL OFFICER 04 Feb 2025, 20:30
TVTX Travere Therapeutics, Inc. 22 Jan 2025 1 -$16,384 4 CHIEF FINANCIAL OFFICER 23 Jan 2025, 20:33
TVTX Travere Therapeutics, Inc. 05 Sep 2024 2 -$28,685 4 CHIEF FINANCIAL OFFICER 09 Sep 2024, 21:20
TVTX Travere Therapeutics, Inc. 04 Sep 2024 1 -$4,888 4 CHIEF FINANCIAL OFFICER 05 Sep 2024, 21:30
TVTX Travere Therapeutics, Inc. 11 Apr 2024 1 -$364 4 CHIEF FINANCIAL OFFICER 12 Apr 2024, 16:05
TVTX Travere Therapeutics, Inc. 31 Jan 2024 3 -$32,573 4 CHIEF FINANCIAL OFFICER 02 Feb 2024, 16:05
TVTX Travere Therapeutics, Inc. 23 Jan 2024 1 -$7,735 4 CHIEF FINANCIAL OFFICER 25 Jan 2024, 16:10
TVTX Travere Therapeutics, Inc. 05 Sep 2023 1 -$6,723 4 Chief Financial Officer 05 Sep 2023, 20:15
TVTX Travere Therapeutics, Inc. 10 May 2023 1 -$7,548 4 Chief Financial Officer 12 May 2023, 16:14
TVTX Travere Therapeutics, Inc. 11 Apr 2023 1 -$1,010 4 Chief Financial Officer 13 Apr 2023, 16:07
TVTX Travere Therapeutics, Inc. 31 Jan 2023 4 -$34,542 4 Chief Financial Officer 02 Feb 2023, 18:02
TVTX Travere Therapeutics, Inc. 24 Jan 2023 1 -$18,663 4 Chief Financial Officer 26 Jan 2023, 15:05
TVTX Travere Therapeutics, Inc. 01 Sep 2022 3 $0 4 Chief Financial Officer 01 Sep 2022, 18:20
TVTX Travere Therapeutics, Inc. 01 Sep 2022 0 $0 3 Chief Financial Officer 01 Sep 2022, 18:19